Bio-Techne Corp (TECH) Ordinary USD0.01

Sell:$51.78Buy:$51.79$0.15 (0.29%)

NASDAQ:0.07%
Market closed |
Prices delayed by at least 15 minutes
Sell:$51.78
Buy:$51.79
Change:$0.15 (0.29%)
Deal now
Market closed |
Prices delayed by at least 15 minutes
Sell:$51.78
Buy:$51.79
Change:$0.15 (0.29%)
Market closed |
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Bio-Techne Corporation develop, manufacture and sell life science reagents, instruments and services for the research, diagnostics and bioprocessing markets worldwide. The Company’s segments include Protein Sciences segment and Diagnostics and Spatial Biology segment. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, advanced tissue-based in-situ hybridization assays and instrumentation for spatial genomic and tissue biopsy analysis and genetic and oncology kits for research and clinical applications. Its product portfolio and application enable scientific investigations into biological processes and molecular diagnostics and progression of specific diseases.

Key people

Kim Kelderman
President, Chief Executive Officer, Chief Operating Officer, Director
James T. Hippel
Chief Financial Officer, Executive Vice President - Finance
William Alexander Geist
President - Protein Sciences
Matthew F. Mcmanus
President - Diagnostics and Genomics Segment
Shane Bohnen
Senior Vice President, General Counsel, Corporate Secretary
Robert V. Baumgartner
Independent Chairman of the Board
Julie L. Bushman
Independent Director
Amy E. Herr
Independent Director
John L. Higgins
Independent Director
Joseph D. Keegan
Independent Director
Click to see more

Key facts

  • EPIC
    TECH
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US09073M1045
  • Market cap
    $7.97bn
  • Employees
    3,100
  • Shares in issue
    155.55m
  • Exchange
    NASDAQ
  • Index
    S&P 500, TR Equity United States Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.